Experts are increasingly investigating retatrutide, a innovative medication developed by Eli Lilly, as a significant breakthrough in weight reduction . Unlike many previous approaches, retatrutide is a twin-action compound targeting equally GLP-1 and GIP, hormones that influence satiety and bloo